Modeling human choroidal melanoma xenograft growth in immunocompromised rodents to assess treatment efficacy

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 6, 2012, Pages 2693-2701

  Braun, Rod D ^a,b   Vistisen, Kerry S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOROID MELANOMA; ECHOGRAPHY; FEMALE; HIGH FREQUENCY ULTRASOUND; MALE; MOUSE; NONHUMAN; NUDE RAT; PRIORITY JOURNAL; RAT; SCID MOUSE; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; UVEA MELANOMA;

ANIMALS; CHOROID NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MELANOMA; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; RATS; RATS, NUDE; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN; TUMOR CELLS, CULTURED;

EID: 84860646108     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-9265     Document Type: Article

References (26)

1. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32:239-251.
2. Sahel JA, Albert DM. Intraocular melanomas. Cancer Treat Res. 1993;65:161-199.
3. Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118: 1881-1885.
4. Damato B. Developments in the management of uveal melanoma. Clin Experiment Ophthalmol. 2004;32:639-647.
5. Robertson DM. Changing concepts in the management of choroidal melanoma. Am J Ophthalmol. 2003;136:161-170.
6. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Oph-thalmol. 2001;119:969-982.
7. COMS. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma: I. visual acuity after 3 years COMS report no. 16. Ophthalmology. 2001;108:348-366.
8. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol. 2000;118:1219-1228.
9. Dendale Lumbroso-Le R, Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay Proton Therapy Center (ICPO). Int J Radiat Oncol Biol Phys. 2006;65:780-787.
10. Wardman P. Chemical radiosensitizers for use in radiotherapy. Clinical Oncology. 2007;19:397-417.
11. Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 2000;60:6950-6957.
12. Stuschke M, Budach V, Bamberg M, Budach W. Methods for analysis of censored tumor growth delay data. Radiat Res. 1990;122:172-180.
13. Braun RD, Vistisen KS. Measurement of human choroidal melanoma xenograft volume in rats using high-frequency ultrasound. Invest Ophthalmol Vis Sci. 2008;49:16-22.
14. Braun RD, Abbas A. Orthotopic human choroidal melanoma xenografts in nude rats with aggressive and nonaggressive PAS staining patterns. Invest Ophthalmol Vis Sci. 2006;47:7-16.
15. Li H, Alizadeh H, Niederkorn JY. Differential expression of chemokine receptors on uveal melanoma cells and their metastases. Invest Ophthalmol Vis Sci. 2008;49:636-643.
16. Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci. 1989;30:829-834.
17. Daniels KJ, Boldt HC, Martin JA, Gardner LM, Meyer M, Folberg R. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression. Lab Invest. 1996; 75:55-66.
18. Folberg R, Kadkol SS, Frenkel S, et al. Authenticating cell lines in ophthalmic research laboratories. Invest Ophthalmol Vis Sci. 2008;49:4697-4701.
19. Bajzer Z, Marušić M., Vuk-Pavlović S. Conceptual frameworks for mathematical modeling of tumor growth dynamics. Math Comput Model. 1996;23:31-46.
20. López S, Prieto M, Dijkstra J, Dhanoa MS, France J. Statistical evaluation of mathematical models for microbial growth. Int J Food Microbiol. 2004;96:289-300.
21. Motulsky HJ, Ransnas LA. Fitting curves to data using nonlinear regression: a practical and nonmathematical review. The FASEB Journal. 1987;1:365-374.
22. Snedecor GW, Cochran WG. Statistical methods, 8th ed. Ames: Iowa State University Press, 1989;503.
23. Zhang Q, Yang H, Kang SJ, et al. In vivo high-frequency, contrast-enhanced ultrasonography of uveal melanoma in mice: imaging features and histopathologic correlations. Invest Ophthalmol Vis Sci. 2011;52:2662-2668.
24. Huang P, Allam A, Taghian A, Freeman J, Duffy M, Suit HD. Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in SCID mice. J Neurosurg. 1995;83:308-315.
25. Flatmark K, Mælandsmo GM, Martinsen M, Rasmussen H, Fodstad Ø. Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. European Journal of Cancer. 2004;40: 1593-1598.
26. Braun RD, Bissig D, North R, Vistisen KS, Berkowitz BA. Human tumor cell proliferation evaluated using manganese-enhanced MRI. PLoS ONE. 2012;7:e30572.